SCHEMBL6909857

SCHEMBL6909857

CNS(=O)(=O)c1ccsc1Oc1cccc(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.41
LMNA P02545 2/20 0.39
NPC1 O15118 1/20 0.38
PKM P14618 1/20 0.38
RAB9A P51151 1/20 0.38
HTR1B P28222 1/20 0.37
KMT2A Q03164 2/20 0.36
NUDT1 P36639 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 5/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 1/20 0.36
KEAP1 Q14145 2/20 0.34
NFE2L2 Q16236 1/20 0.33
POLB P06746 1/20 0.33
CRHBP P24387 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6909644 0.87 LMNA (0.40) CASP1LMNAPKMKMT2AMEN1
SCHEMBL6909778 0.81 CASP1 (0.41) CASP1LMNANPC1PKMRAB9A
SCHEMBL3702725 0.71 LMNA (0.48) LMNAPKMKMT2AALDH1A1GAA
SCHEMBL6903887 0.68 EDNRB (0.37) CASP1LMNAKMT2AALDH1A1GAA
SCHEMBL30338563 0.68 LMNA (0.57) LMNAPKMKMT2AALDH1A1MAPT
SCHEMBL634340 0.68 LMNA (0.57) LMNAPKMKMT2AALDH1A1MAPT
SCHEMBL1538371 0.67 MAPT (0.54) CASP1NPC1RAB9AHTR1BKMT2A
SCHEMBL29377898 0.67 MAPT (0.54) CASP1NPC1RAB9AHTR1BKMT2A
Formaldehyde SCHEMBL27667426 0.66 MAPT (0.53) CASP1LMNARAB9AHTR1BKMT2A
SCHEMBL5680726 0.64 CASP1 (0.52) CASP1HTR1BKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6683103-B2 SULFONAMIDES CONTAINING OXAZOLE AND SUBSTITUTED THIOPHENE RINGS, USEFUL FOR TREATING HYPERTENSION, CARDIOVASCULAR DISEASE, ASTHMA, PULMONARY HYPERTENSION, INFLAMMATORY DISEASES, VISION DEFECTS, MENSTRUAL DISORDERS, RENAL FAILURE TEXAS BIOTECHNOLOGY CORPORATION 2004-01-27 US disclosed
US-6632829-B2 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases TEXAS BIOTECHNOLOGY CORP. 2003-10-14 US disclosed
US-6613804-B2 Treatment of hypertension, cardiovascular disease, pulmonary hypertension, erythropoietin-mediated vasoconstriction, endotoxin shock, pulmonary hypertension, anaphylactic shock and hemorrhagic shock ENCYSIVE PHARMACEUTICALS, INC. 2003-09-02 US disclosed
US-6458805-B2 ANTAGONISTS; ESPECIALLY SODIUM SALTS TEXAS BIOTECHNOLOGY CORPORATION 2002-10-01 US disclosed
US-6432994-B1 CARDIOVASCULAR DISORDERS, GLAUCOMA; ANTIINFLAMMATORY, WOUND HEALING, HYPOTENSIVE, ANTIASTHMATIC, AND ANTIANAPHYLACTIC AGENTS TEXAS BIOTECHNOLOGY CORPORATION 2002-08-13 US disclosed
US-6342610-B2 COMPOUNDS SUCH AS N-(4-BROMO-3-METHYL-5-ISOXAZOLYL)-2-N-BENZYLBENZO(B)THIOPHENE-3-SUFONAMIDE ADMINISTERED AS ENDOTHELIN PEPTIDE RECEPTOR ANTAGONISTS TEXAS BIOTECHNOLOGY CORP. 2002-01-29 US disclosed
US-6331637-B1 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION 2001-12-18 US disclosed
US-6248767-B1 VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORP. 2001-06-19 US disclosed